A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Salmon Calcitonin


Emisphere Announces Initiation Of Phase III Clinical Program Of ...  -  25 May 2007
Medical News Today (press release),The salmon calcitonin is formulated in tablet form using Emisphere's novel eligen(R) delivery technology. Emisphere's technology creates the potential for

Emisphere Technologies Announces 2007 First Quarter Financial Results  -  May 4, 2007
PR Newswire (press release),This increase was due to the commencement of the Phase III testing on Oral Salmon Calcitonin by Novartis under the Company's collaboration with them.

Emisphere Technologies to Hold Annual Stockholders Meeting on ...  -  Apr 18, 2007
PharmaLive.com (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Initiation of Phase III Program Using Emisphere's eligen ...  -  Feb 27, 2007
PharmaLive.com (press release),The use of Emisphere's novel eligen(R) technology reflects the potential that for the first time salmon calcitonin may also be available as a convenient

Market Report -- In Play (EMIS)  -  Feb 27, 2007
MSN MoneyEmisphere Tech announces initiation of Phase 3 clinical trial for oral form of salmon calcitonin Emisphere Technologies (EMIS) announces that Novartis

Unigene Achieves $5.5 Million Milestone in Calcitonin ...  -  Feb 27, 2007
NJBIZ,Salmon calcitonin, the active pharmaceutical ingredient in Novartis’ oral product, was produced using Unigene’s patented manufacturing process,

Emisphere Technologies, Inc. Forms Oral Insulin Scientific ...  -  Mar 20, 2007
PR Newswire (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Emisphere Technologies, Inc. to Hold Teleconference to Discuss ...  -  Feb 22, 2007
PharmaLive.com (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Emisphere Announces Executive Management Changes  -  Jan 16, 2007
Drug Newswire (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Emisphere Technologies, Inc. Presentation at Lazard Capital ...  -  Nov 28, 2006
PR Newswire (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ...

Emisphere Reports Additional Clinical Data From Phase 2 Oral ...  09 Nov 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... -Medical News Today (press release), Nastech Pharma Presents Scientific Abstracts - Quick Facts  Nov 2, 2006
...(NSTK | charts | news | PowerRating) presented abstract on a 2x2 Replicate Bioequivalence Study of Two Formulations of Salmon Calcitonin Administered via ... -Trading Markets, Emisphere Technologies Presentation at Oppenheimer Diabetes ...  Sep 20, 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... -PharmaLive.com

Emisphere's Eligen(R) Technology Demonstrates Delivery Of Active ...  Sep 6, 2006
In 2000, Emisphere and Novartis Pharma AG entered into a license agreement for the development of oral salmon calcitonin for the treatment of osteoporosis; in ... -Medical News Today

Emisphere Technologies, Inc. Presentation at Lazard Capital ...  -  Nov 28, 2006
PharmaLive.com (press release),Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone

Emisphere Technologies Announces 2006 Second Quarter Financial ...  Aug 8, 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... -MSN Money

Emisphere Announces New Multi-Product Research Collaboration ...  Jul 18, 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... -PR Newswire



Emisphere Technologies Completes Sale of Common Stock  16 May 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... - Yahoo! News

Emisphere to Receive Milestone Payment for eligen(R) Technology to ...  May 1, 2006
In 2000, Emisphere and Novartis entered into a license agreement for the development of oral salmon calcitonin for the treatment of osteoporosis; in 2004, the ... - Yahoo! News





Emisphere Completes Enrollment for Phase II Oral Insulin Clinical ...  11 Apr 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... - PR Newswire

Emisphere Technologies, Inc. Announces Fourth Quarter and Year End ...  Mar 14, 2006
Oral Salmon Calcitonin During the third quarter, Novartis Pharma AG (Novartis) and Nordic Bioscience A/S (Nordic Bioscience) informed Emisphere that they had ... - PR Newswire

Emisphere Technologies, Inc. Announces Fourth Quarter and Year En ...  Mar 14, 2006
...informed Emisphere that they had met with the FDA to discuss their Phase III development plan for the oral formulation of salmon calcitonin (CT) for the ... - PharmaLive.com

Emisphere Technologies 4Q losses deepen  Mar 14, 2006
M. Goldberg noted that the company has two products set to begin "pivotal" late-stage, Phase III clinical trials this year: oral salmon calcitonin to treat the ... - BusinessWeek

Emisphere Announces Oral PTH License Agreement  Mar 8, 2006
...the third between the two companies: In 2000, Emisphere and Novartis entered into a license agreement for the development of oral salmon calcitonin, and a ... - PR Newswire



Emisphere Technologies Announces Presentation and Webcast at the ...  Mar 1, 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... - PR Newswire,

Emisphere Technologies Responds to Eli Lilly Motion  Feb 7, 2006
Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and ... - Yahoo! News


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional